Demand-Based CSR Therapy Prediction for Implantable Devices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current techniques for treating Cheyne-Stokes Respiration (CSR) using implantable medical devices often deliver therapy continuously, regardless of whether sleep interruptions are likely to occur, leading to unnecessary resource depletion and potential adverse effects such as atrial fibrillation and nerve damage.

Innovation Solution

Implementing a demand-based therapy system that predicts whether a patient will awaken due to periodic breathing episodes, delivering aggressive therapy only when necessary to prevent sleep interruptions, thus conserving device resources and minimizing side effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If continuous therapy is delivered to treat CSR, then sleep interruptions are prevented, but device resources are depleted unnecessarily and adverse effects increase

Engineering Contradiction:
Improvesleep interruption preventionVSAvoiddevice resource depletion
Core Design Contradiction:
ReliabilityVSLoss of energy

Solution Approach 1:

The system dynamically adjusts therapy delivery based on real-time prediction of sleep interruption risk. Instead of continuous static therapy, the system modulates pacing intensity and duration according to the detected respiratory pattern and predicted outcome, optimizing resource utilization while maintaining sleep interruption prevention.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system incorporates feedback loops that continuously monitor respiratory parameters, predict sleep interruption risk, and adjust therapy delivery accordingly. This closed-loop control ensures therapy is delivered only when and where needed, preventing resource depletion while maintaining effectiveness.

Inventive Principle:
Principle #23Feedback

2Reliability

If aggressive therapy is delivered continuously, then sleep interruptions are prevented, but adverse effects such as atrial fibrillation and nerve damage occur

Engineering Contradiction:
Improvesleep interruption preventionVSAvoidadverse effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system applies partial action by delivering therapy only when predicted to be necessary, rather than continuous aggressive therapy. The pacing intensity is modulated to the minimum effective level required to prevent sleep interruption, avoiding excessive action that causes adverse effects like atrial fibrillation and nerve damage.

Inventive Principle:
Principle #16Partial or excessive action

Solution Approach 2:

Instead of continuous aggressive therapy, the system employs periodic action by delivering pacing only during predicted apneic episodes. The therapy is intermittent and targeted, reducing cumulative stress on the heart and nerves while maintaining sleep interruption prevention.

Inventive Principle:
Principle #19Periodic action

3Loss of energy

If demand-based therapy is implemented, then device resources are conserved, but prediction accuracy is required to avoid unnecessary therapy

Engineering Contradiction:
Improvedevice resource conservationVSAvoidprediction accuracy
Core Design Contradiction:
Loss of energyVSMeasurement precision

Solution Approach 1:

The system performs preliminary prediction of sleep interruption risk before delivering therapy. By analyzing respiratory patterns in advance and predicting whether apnea will occur, the system can proactively adjust therapy delivery, conserving resources while maintaining accuracy through advance assessment rather than reactive response.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS7357775B1System and method for providing demand-based Cheyne-Stokes Respiration therapy using an implantable medical device
Publication Date: 2008.04.15 PACESETTER INC
  • US7357775B1 patent drawing
  • US7357775B1 patent drawing
  • US7357775B1 patent drawing

AI summary

Techniques are provided for controlling therapy delivered in response to Cheyne-Stokes Respiration (CSR) or other forms of periodic breathing in an effort to reduce the likelihood of unnecessary therapy directed toward preventing sleep interruption. Following each burst of respiration during CSR, a prediction is made as to whether the amount of respiration achieved during the burst will be sufficient to sustain the patient through a period of apnea until the next respiration burst. If not, aggressive therapy, such as aggressive diaphragmatic pacing, is delivered to improve respiration and prevent the imminent sleep interruption. If, however, the amount of respiration achieved during the burst appears to be sufficient to sustain the patient until the next respiration burst, then relatively mild therapy is instead delivered. Preferably, the prediction is made by comparing respiration achieved during a CSR respiration burst against the minimal respiration demands of the patient, evaluated based on respiration occurring shortly after the onset of sleep.